Major pharmaceutical investments in the United States are expanding API, capsule, and packaging capacity, enhancing supply chain resilience and supporting domestic drug production.

At CPHI and AAPS, Ashland plans to detail the impacts of its advanced excipients: ultra-low nitrite materials curb ...

In episode 27, Christopher Hopkins, PhD; Omkar Kawalekar, PhD; Barnaby Pickering; and Jerry Rosenbaum, MD, go behind the ...

The first needle-free adrenaline treatment launches in the UK, validating non-invasive delivery with real-world data ...

Biopharma data showed M&A strength, selective venture capital favoring Phase II, record obesity deals, and significant ...

M&A favors late-stage assets, obesity deals surge, AI accelerates manufacturing, and policy drives strategic US facility ...

As the conference approaches, scientists are reviewing new technologies that enhance manufacturing process control, product ...

Advanced biotech equipment, driven by R&D investment and personalized medicine, is essential for scalable drug production and ...

This article outlines common CMC problems that are obstacles that steal momentum and create costly detours in the development ...

Hibreniguss Terefe, is director, Product Development Somerset Ardena.

ICE Pharma will present its bile acid-derived innovations and sustainability strategies at CPHI Frankfurt 2025. The company's ...